Patent Assignment
Reel/Frame 021602/0423
Security Agreement
Recorded: 2008-09-29
Pages: 11
Assignor
NUCLEONICS, INC.
Executed: 2008-07-11
Assignees
NEW ENTERPRISE ASSOCIATES 10, LIMITED PARTNERSHIP
1119 ST. PAUL STREET, BALTIMORE, MARYLAND, 21202
S.R. ONE, LIMITED
161 WASHINGTON STREET, SUITE 500, EIGHT TOWER BRIDGE, CONSHOHOCKEN, PENNSYLVANIA, 19428-2077
OFCO CLUB IV
C/O ODLANDER, FREDRIKSON & CO AB, STRANDVAGEN 5B, STOCKHOLM, SE-114 51, SWEDEN
HEALTHCAP IV KB
STRANDVAGEN 5B, STOCKHOLM, SE-114 51, SWEDEN
HEALTHCAP IV, L.P.
C/O HEALTH CAP IV, GP S.A., 18 AVENUE D'OUCHY, LAUSANNE, CH-1006, SWITZERLAND
HEALTHCAP IV BIS, L.P.
C/O HEALTH CAP IV, GP S.A., 18 AVENUE D'OUCHY, LAUSANNE, CH-1006, SWITZERLAND
BURRILL LIFE SCIENCES CAPITAL FUND, L.P.
ONE EMBARCADERO CENTER, SUITE 2700, SAN FRANCISCO, CALIFORNIA, 94111
BURRILL INDIANA LIFE SCIENCES CAPITAL FUND, L.P.
ONE EMBARCADERO CENTER, SUITE 2700, SAN FRANCISCO, CALIFORNIA, 94111
QUAKER BIOVENTURES, L.P.
CIRA CENTRE, 2929 ARCH STREET, PHILADELPHIA, PENNSYLVANIA, 19104-2868
QUAKER BIOVENTURES TOBACCO FUND, L.P.
CIRA CENTRE, 2929 ARCH STREET, PHILADELPHIA, PENNSYLVANIA, 19104-2868
POSCO BIOVENTURES I, L.P.
2121 PALOMAR AIRPORT ROAD, SUITE 300, CARLSBAD, CALIFORNIA, 92009
Covered Properties
(28)
Load Floor System
Patent:
6,752,443 →
Application:
10/009,234 →
Use of post-transcriptional gene silencing for identifying nucleic acid sequences that modulate the function of a cell
Application:
10/062,707 →
Publication:
US 2002/0132257
Methods and compositions for silencing genes without inducing toxicity
Application:
10/425,006 →
Publication:
US 2004/0180438
Methods for delivery of nucleic acids
Application:
10/513,708 →
Publication:
US 2006/0084617
Double stranded rna structures and constructs, and methods for generating and using the same
Application:
10/522,962 →
Publication:
US 2005/0239728
Double-stranded rna structures and constructs, and methods for generating and using the same
Application:
10/531,349 →
Publication:
US 2006/0035344
Methods and constructs for evaluation of rnai targets and effector molecules
Application:
10/547,256 →
Publication:
US 2006/0263764
Conserved Hbv and Hcv Sequences Useful for Gene Silencing
Post-Transcriptional Gene Silencing Using Expressed Double Stranded Rna
Methods and compositions for inhibiting the function of polynucleotide sequences
Application:
10/773,735 →
Publication:
US 2004/0138168
Methods and compositions for inhibiting the function of polynucleotide sequences
Application:
10/780,450 →
Publication:
US 2004/0147476
Transfection Kinetics and Structural Promoters
Methods and compositions for inhibiting the function of polynucleotide sequences
Application:
10/836,856 →
Publication:
US 2004/0198690
Methods and compositions for inhibiting the function of polynucleotide sequences
Application:
10/897,361 →
Publication:
US 2004/0266721
Methods and compositions for inhibiting the function of polynucleotide sequences
Application:
10/912,438 →
Publication:
US 2005/0004067
Methods and compositions for inhibiting the function of polynucleotide sequences
Application:
10/916,043 →
Publication:
US 2005/0043267
Methods and compositions for inhibiting the function of polynucleotide sequences
Application:
10/920,965 →
Publication:
US 2005/0054603
Methods and compositions for inhibiting the function of polynucleotide sequences
Application:
10/949,845 →
Publication:
US 2005/0064496
Methods and compositions for inhibiting the function of polynucleotide sequences
Application:
10/977,537 →
Publication:
US 2005/0239202
Methods and compositions for inhibiting the function of polynucleotide sequences
Application:
11/333,672 →
Publication:
US 2006/0104956
Methods and compositions for silencing genes without inducing toxicity
Application:
11/542,291 →
Publication:
US 2007/0027103
Methods and compositions for inhibiting the function of polynucleotide sequences
Application:
11/606,550 →
Publication:
US 2008/0081792
Methods and compositions for inhibiting the function of polynucleotide sequences
Application:
11/606,590 →
Publication:
US 2007/0238178
Methods and compositions for inhibiting the function of polynucleotide sequences
Application:
11/638,734 →
Publication:
US 2007/0219151
Methods and compositions for inhibiting the function of polynucleotide sequences
Application:
11/638,809 →
Publication:
US 2007/0232557
Multiple Rna Polymerase Iii Promoter Expression Constructs
Transfection Kinetics and Structural Promoters
Methods and Compositions for Inhibiting the Function of Polynucleotide Sequences
Application:
12/106,649 →
Publication:
US 2008/0194514
Related Assignments
(13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 12, 2002
From: ANDERSON, RICK A.; THOMPSON, JOSEPH M.
To: JOHNSON CONTROLS TECHNOLOGY COMPANY
Reel/Frame 012784/0565 →
Assignment of Assignor's Interest
May 22, 2002
From: GIORDANO, TONY; PACHUK, CATHERINE J.; SATISCHANDRAN, C.
To: NUCLEONICS, INC.
Reel/Frame 013545/0719 →
Assignment of Assignor's Interest
Oct 22, 2004
From: MESSAGE PHARMACEUTICALS, INC.
To: NUCLEONICS, INC.
Reel/Frame 015284/0682 →
Assignment of Assignor's Interest
Nov 4, 2004
From: PACHUK, CATHERINE J.; SATISHCHANDRAN, C.
To: NUCLEONICS, INC.
Reel/Frame 015339/0274 →
Assignment of Assignor's Interest
Mar 17, 2005
From: PACHUK, CATHERINE J.
To: NUCLEONICS, INC.
Reel/Frame 015919/0756 →
Assignment of Assignor's Interest
Jun 7, 2005
From: SATISHCHANDRAN, C.
To: NUCLEONICS, INC.
Reel/Frame 016306/0894 →
Assignment of Assignor's Interest
Jun 8, 2005
From: PACHUK, CATHERINE; SATISHCHANDRAN, C.; MCCALLUS, DANIEL E.
To: NUCLEONICS, INC.
Reel/Frame 016313/0619 →
Assignment of Assignor's Interest
Jun 8, 2005
From: PACHUK, CATHERINE; SATISHCHANDRAN, C.; CHOPRA, MANINDER; SHUEY, DAVID
To: NUCLEONICS, INC.
Reel/Frame 016313/0637 →
Assignment of Assignor's Interest
Aug 16, 2007
From: PACHUK, CATHERINE J.; SATISHCHANDRAN, CHANDRASEKHAR; ZURAWSKI, VINCENT R.; MINTZ, LIAT
To: NUCLEONICS, INC.
Reel/Frame 019705/0646 →
Assignment of Assignor's Interest
Apr 9, 2008
From: WYETH
To: NUCLEONICS, INC.
Reel/Frame 020778/0766 →
Release of Security Interest
Dec 5, 2008
From: NEW ENTERPRISE ASSOCIATES 10, LIMITED PARTNERSHIP; BURRILL LIFE SCIENCES CAPITAL FUND, L.P.; BURRILL INDIANA LIFE SCIENCES CAPITAL FUND, L.P.; OFCO CLUB IV
To: NUCLEONICS, INC.
Reel/Frame 021932/0001 →
Assignment of Assignor's Interest
Mar 12, 2009
From: NUCLEONICS, INC.
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 022386/0468 →
Security Interest
Oct 1, 2025
From: ALNYLAM PHARMACEUTICALS, INC.; SIRNA THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 072996/0337 →